LIFE - Atyr Pharma Inc
Close
1.9
0.050 2.632%
Share volume: 269,477
Last Updated: Tue 04 Jun 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.85
0.05
2.70%
Summary score
8%
Profitability
0%
Dept financing
6%
Liquidity
75%
Performance
0%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Sep-2019 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-13.78%
Return on assets
-11.23%
Return on sales
-2072.71%
Return on invested capital
-358.68%
Total debt ratio
17.98%
Debt ratio change over timeo
-0.99%
Current Ratio
9.17%
Quick Ratio
10.38%
Cash Position Ratio
8.38%
Short-term ratios 30-Sep-2022 - 30-Sep-2023
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.13%
Return on assets
-9.49%
Return on sales
-1825.1%
Return on invested capital
-368.34%
Total debt ratio
21.6%
Debt ratio change over timeo
-1.03%
Current Ratio
8.04%
Quick Ratio
8.04%
Cash Position Ratio
7.46%
Last quarter ratios 30-Sep-2023
The data are presented for the financials results of the last quarter.
Return on equity
-11.53%
Return on assets
-10.09%
Return on sales
-3573.65%
Return on invested capital
-231.9%
Total debt ratio
21.33%
Debt ratio change over time
-1.09%
Current Ratio
8.33%
Quick Ratio
8.33%
Cash Position Ratio
7.93%
Performance ratios (change over 4 years) 30-Sep-2019 - 30-Sep-2023
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-100.13%
Return on assets
-100%
Return on sales
-316.29%
Return on invested capital
2.58%
Total debt ratio
-98.86%
Debt ratio change over time
-0.99%
Current Ratio
0.71%
Quick Ratio
1.57%
Cash Position Ratio
0.9%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LIFE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -13.78% | 7.58% | 36.15% | 7.75% |
| Return on assets | -11.23% | 2.95% | 3.44% | 5.85% |
| Return on sales | -2072.71% | 30.63% | 35.3% | 41.32% |
| Return on invested capital | -358.68% | 3.7% | 6.05% | 20.44% |
| Profitability | 0% | 41% | 68% | 80% |
| Total debt ratio | 17.98% | 92.36% | 89.3% | 27.07% |
| Debt ratio change over time | -0.99% | 292.67% | 15.45% | 1.02% |
| Dept financing | 5% | 50% | 25% | 7% |
| Current Ratio | 8.04% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 8.04% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 7.46% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 8% | 12% | 26% |
| Short-term ratios | LIFE | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -11.13% | 11.57% | 35.05% | 4.21% |
| Return on assets | -9.49% | 2.86% | 2.7% | 3.6% |
| Return on sales | -1825.1% | 27.99% | 31.88% | 33.53% |
| Return on invested capital | -368.34% | 2.16% | 6.93% | 9.79% |
| Profitability | 0% | 54% | 85% | 78% |
| Total debt ratio | 21.6% | 89.83% | 93.1% | 22.12% |
| Debt ratio change over time | -1.03% | 102.83% | 13.09% | 1.3% |
| Dept financing | 6% | 49% | 28% | 6% |
| Current Ratio | 8.04% | 0.94% | 2.55% | 5.29% |
| Quick Ratio | 8.04% | 0.82% | 2.23% | 4.52% |
| Cash Position Ratio | 7.46% | 0.3% | 1.72% | 2.75% |
| Liquididy | 75% | 6% | 21% | 40% |